New Oral Drug Approved for Herpes Lesions

(MedPage Today) -- The FDA approved pritelivir (Hovilpri) tablets to treat mucocutaneous lesions caused by herpes simplex virus (HSV) infections in immunocompromised patients who haven't responded to other treatments.
Pritelivir, an oral helicase...